Widespread distribution of nirsevimab to infants with respiratory syncytial virus infection raised concerns about potential ...

As infection rates of illnesses carried by mosquitoes increase, companies and researchers are racing to develop effective ...

Recruitment is underway for a clinical trial testing a vaccine candidate produced with The University of Queensland's molecular clamp technology against life-threatening respiratory viruses.

Infants are among the most susceptible to respiratory complications from respiratory syncytial virus, or RSV. While they can ...

Here's what experts say about using antibiotics to treat the common cold — and why you can still catch one in the summer.

Infant deaths during a trial of a medicine that protects against respiratory syncytial virus were caused by unrelated factors ...

Current guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV)—which typically causes mild, cold-like symptoms in most adults but can be deadly for ...

The following is a summary of “EDP-938 has a high barrier to resistance in healthy adults experimentally infected with ...

Recruitment is underway for a clinical trial testing a vaccine candidate produced with The University of Queensland's ...